University of Avignon   Report issue

Academic/Hospital
Founded: Avignon France (1303)

Organization Overview

First Clinical Trial
2014
NCT03492593
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Avignon University | INRA/Université d'Avignon | Laboratory of Cardiovascular Pharm-Ecology, Faculty of Health and Sciences, university of Avignon, 33 rue louis pasteur 84000 Avignon, France. | University of Avignon

Active Ingredients

Drugs in Other Trials (4)

beta carotene (solatene) (1 trial)

dobutamine (dobutrex) (1 trial)

lycopene (1 trial)

vitamin d3 (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 3
  • # of Trial APIs: 4